United States · Biotechnology startup
United States · Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Funding reportedLast round: Debt financing
What company datasets say Tarsa Therapeutics raised
Funding, as reported
Reported in all$124Min dollars
Rounds9
Last roundDebt financing
Last round dateJul 2016
Investors listed9
Founders and team
From the SEC filings it signed: 2 on the team.
- David BrandExecutive Officer, Directori
- Gregory LumpkinExecutive Officeri
On the board, as filediEric BednarskiMartin EdwardsRichard KollenderRichard Levy
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Tarsa Therapeutics in front of investors. Or tell us what we have wrong.